Finance News – Hengrui Pharma

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Shares Tariffs Ceo Investors Stock Stock Market Crypto Assets Cryptocurrency Ethereum Price Markets Xrp Bse Etf Eth Stablecoin Investment Blockchain Ipo Index Solana Earnings Sec Revenue Trade Inflation Interest Rates Sensex Token Coinbase Wall Street Treasury Nasdaq Federal Reserve Nse Bse Sensex Traders China Nifty Sp 500 Profit Gold Investor Tesla Company Economy Decentralized Laf Corridor Tax Thresholds Phoenix Group Qatar Airways Bullish Channel Us Fiscal Health Sustainability Ratings Gaming Licence Rics

Filter by:

Hengrui Pharma ×

CNBC Business • Jul 16, 2025

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

The success of a new obesity medication in China could challenge existing market leaders, potentially shifting investment dynamics within the pharmaceutical sector and impacting fu...

Read Full Article →